We are live on ! Find out more
TNDM icon

Tandem Diabetes Care

75 hedge funds and large institutions have $106M invested in Tandem Diabetes Care in 2018 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,602% more capital invested

Capital invested by funds: $3.92M → $106M (+$102M)

413% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 8

400% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 4

79% more funds holding

Funds holding: 4275 (+33)

31.3% more ownership

Funds ownership: 16.41%47.71% (+31%)

Holders
75
Holders Change
+33
Holders Change %
+78.57%
% of All Funds
1.72%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
41
Increased
20
Reduced
4
Closed
8
Calls
$4.46M
Puts
Net Calls
+$4.46M
Net Calls Change
+$2.33M
Name Holding Trade Value Shares
Change
Change in
Stake
SIM
26
Spark Investment Management
New York
$566K +$369K +114,300 New
KeyBank National Association
27
KeyBank National Association
Ohio
$559K +$294K +91,300 +428%
TEE
28
Tibra Equities Europe
United Kingdom
$429K +$279K +86,447 New
Northern Trust
29
Northern Trust
Illinois
$415K +$270K +83,747 New
Westfield Capital Management
30
Westfield Capital Management
Massachusetts
$378K +$246K +76,300 New
DCM
31
DAFNA Capital Management
California
$298K +$193K +60,000 New
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$260K -$85.6K -26,536 -34%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$244K +$159K +49,365 New
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$236K +$153K +47,500 +2,375,000%
Barclays
35
Barclays
United Kingdom
$234K +$65.5K +20,300 +76%
FMT
36
First Mercantile Trust
Tennessee
$223K +$132K +40,969 +1,051%
BlackRock
37
BlackRock
New York
$207K -$780 -242 -0.6%
Squarepoint
38
Squarepoint
New York
$198K +$129K +39,898 New
TAM
39
Tocqueville Asset Management
New York
$197K +$128K +39,800 New
ARTA
40
A.R.T. Advisors
New York
$191K +$91.9K +28,499 +284%
ECM
41
Element Capital Management
New York
$184K +$120K +37,180 New
AFP
42
Ausdal Financial Partners
Iowa
$172K +$16.1K +5,000 +17%
State Street
43
State Street
Massachusetts
$168K +$109K +33,949 New
WS
44
Wedbush Securities
California
$161K +$9.4K +2,915 +10%
Creative Planning
45
Creative Planning
Kansas
$129K +$25.8K +8,000 +44%
CAN
46
Cetera Advisor Networks
California
$117K +$75.8K +23,500 New
BFM
47
Boothbay Fund Management
New York
$104K +$67.7K +21,000 New
GF
48
Gabelli Funds
New York
$102K +$66.5K +20,635 New
FAM
49
Fred Alger Management
New York
$99K +$64.5K +20,000 New
Morgan Stanley
50
Morgan Stanley
New York
$88K +$57K +17,678 +176,780%

TNDM Hedge Fund Activity: Q1 2018 in Review

75 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2018, worth a combined $106M — up 2,602% from $3.92M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new TNDM positions and 8 closed out — a net gain of 33 holders — while 20 added to existing stakes and 4 trimmed.

The largest buyer was First Light Asset Management, opening a new position worth an estimated $15.3M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $449K sold.

  • 75 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2018, up from 42 in Q4 2017.
  • Funds reported $106M of Tandem Diabetes Care stock for Q1 2018, up 2,602% quarter-over-quarter.
  • 41 funds opened new Tandem Diabetes Care positions in Q1 2018 and 8 closed out, a net change of +33 holders.
  • The largest Tandem Diabetes Care buyer in Q1 2018 was First Light Asset Management, an estimated $15.3M added.
  • The largest Tandem Diabetes Care seller in Q1 2018 was Alyeska Investment Group, an estimated $449K sold.

Based on aggregated 13F filings for Q1 2018.